White Pine Capital LLC purchased a new position in shares of Electromed, Inc. (NYSE:ELMD – Free Report) in the 3rd quarter, Holdings Channel reports. The firm purchased 69,937 shares of the company’s stock, valued at approximately $1,974,000.
A number of other hedge funds and other institutional investors have also modified their holdings of ELMD. Bernicke Wealth Management Ltd. bought a new stake in shares of Electromed during the 3rd quarter worth approximately $921,000. Russell Investments Group Ltd. lifted its holdings in shares of Electromed by 76.1% during the third quarter. Russell Investments Group Ltd. now owns 3,416 shares of the company’s stock worth $96,000 after buying an additional 1,476 shares in the last quarter. Ritholtz Wealth Management grew its position in shares of Electromed by 158.1% during the 3rd quarter. Ritholtz Wealth Management now owns 14,436 shares of the company’s stock worth $408,000 after purchasing an additional 8,843 shares in the last quarter. State of Wyoming acquired a new position in Electromed in the 3rd quarter valued at $49,000. Finally, Simplicity Wealth LLC acquired a new stake in Electromed during the third quarter worth about $300,000. Institutional investors and hedge funds own 40.82% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on ELMD. Lake Street Capital boosted their price target on Electromed from $36.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, August 26th. Morgan Stanley set a $50.00 price objective on shares of Electromed in a research note on Wednesday, August 26th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $43.75.
Get Our Latest Research Report on ELMD
Electromed Stock Performance
Shares of NYSE ELMD opened at $24.32 on Monday. The company has a market capitalization of $201.54 million, a P/E ratio of 32.43 and a beta of 0.43. Electromed, Inc. has a 52-week low of $23.01 and a 52-week high of $47.40. The company’s 50 day moving average price is $27.22 and its 200-day moving average price is $31.22.
Electromed Profile
Electromed, Inc. develops, manufactures and markets airway clearance products for people who have difficulty clearing mucus from their lungs. Its products use high-frequency chest wall oscillation, a therapy that applies gentle vibrations to the chest to help loosen and move airway secretions. The company’s main product line is the SmartVest Airway Clearance System, which includes wearable vests and related equipment. These systems are used in managing conditions associated with impaired mucus clearance, including bronchiectasis, cystic fibrosis and certain neuromuscular disorders.
Further Reading
- Five stocks we like better than Electromed
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding ELMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Electromed, Inc. (NYSE:ELMD – Free Report).
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.
